Found 88 matching trials
IPI Biochemotherapy for Chemonaive Patients With Metastatic Melanoma
PHASE1The goal of the Phase I part of this clinical research study is to find the...
Location
University of Texas MD Anderson Cancer Center
Genetically Engineered PBMC and PBSC Expressing NY-ESO-1 TCR After a Myeloablative Conditioning Regimen to Treat Patients With Advanced Cancer
PHASE1This phase I clinical trial evaluates the safety and feasibility of adminis...
Location
UCLA / Jonsson Comprehensive Cancer Center
Gene-Modified White Blood Cells Followed By Interleukin-2 and Vaccine Therapy in Treating Patients With Metastatic Melanoma
PHASE1RATIONALE: Inserting a gene that has been created in the laboratory into a ...
Location
Warren Grant Magnuson Clinical Center - NCI Clinical Trials Referral Office
Suicide Plus Immune Gene Therapy for Advanced Melanoma
EARLY_PHASE1Safety evaluation of combined immunogene therapy in patients with advanced ...
Location
Hospital Italiano
A Study of GPC3 Redirected Autologous T Cells for Advanced HCC
PHASE1Intravenous infusion of CART cells in the treatment of solid tumors may be ...
Location
Renji Hospital, Shanghai Jiao Tong University School of Medicine
Genetically Modified T Cells in Treating Patients With Stage III-IV Non-small Cell Lung Cancer or Mesothelioma
PHASE1This phase I/II trial studies the side effects and best dose of genetically...
Location
Fred Hutch/University of Washington Cancer Consortium
Treating High Risk Leukemia With CD40 Ligand & IL-2 Gene Modified Tumor Vaccine
PHASE1This research study is to determine the safety and dosage of special cells ...
Location
Texas Children's Hospital GCRC
Gene-Modified T Cells, Vaccine Therapy, and Ipilimumab in Treating Patients With Locally Advanced or Metastatic Malignancies
PHASE1This pilot phase I trial studies the side effects of taking ipilimumab afte...
Location
Jonsson Comprehensive Cancer Center
Radiation, Chemotherapy, Vaccine and Anti-MART-1 and Anti-gp100 Cells for Patients With Metastatic Melanoma
PHASE2Background:
* Melanoma antigen recognized by T-cells (MART-1) and gp100 ar...
Location
National Institutes of Health Clinical Center, 9000 Rockville Pike
Safety and Survival of Genetically Modified White Blood Cells in HIV-Infected Persons - A Study in Identical Twin Pairs
N/AThis study will evaluate the safety of giving lymphocytes (white blood cell...
Location
National Institute of Allergy and Infectious Diseases (NIAID)